Abstract:Arterial calcification is an important hallmark of cardiovascular disease and shares many similarities with skeletal mineralisation. The bone‐specific protein osteocalcin (OCN) is an established marker of vascular smooth muscle cell (VSMC) osteochondrogenic trans‐differentiation and a known regulator of glucose metabolism. However, the role of OCN in controlling arterial calcification is unclear. We hypothesised that OCN regulates calcification in VSMCs and sought to identify the underpinning signalling pathways. Immunohistochemistry revealed OCN co‐localisation with VSMC calcification in human calcified carotid artery plaques. Additionally, 3 mM phosphate treatment stimulated OCN mRNA expression in cultured VSMCs (1.72 fold; p < 0.001). Phosphate‐induced calcification was blunted in VSMCs derived from OCN null mice (Ocn−/−) compared to cells derived from Wild‐Type (WT) mice (0.37 fold, p < 0.001). Ocn−/− VSMCs showed reduced mRNA expression of the osteogenic marker Runx2 (0.51 fold, p < 0.01) and the sodium‐dependent phosphate transporter, PiT1 (0.70 fold, p < 0.001), with an increase in the calcification inhibitor Mgp (1.42 fold, p < 0.05) compared to WT. Ocn−/− VSMCs also showed reduced mRNA expression of Axin2 (0.13 fold; p < 0.001) and Cyclin D (0.71 fold; p < 0.01), markers of Wnt signalling. CHIR99021 (GSK3β inhibitor) treatment increased calcium deposition in WT and Ocn−/− VSMCs (1 μM; p < 0.001). Ocn−/− VSMCs however calcified less than WT cells (1 μM; 0.27 fold; p < 0.001). Ocn−/− VSMCs showed reduced mRNA expression of Glut1 (0.78 fold p < 0.001), Hex1 (0.77 fold p < 0.01) and Pdk4 (0.47 fold p < 0.001). This was accompanied by reduced glucose uptake (0.38 fold, p < 0.05). Subsequent mitochondrial function assessment revealed increased ATP‐linked respiration (1.29 fold, p < 0.05), spare respiratory capacity (1.59 fold, p < 0.01) and maximal respiration (1.52 fold, p < 0.001) in Ocn−/− versus WT VSMCs. Together these data suggest that OCN plays a crucial role in arterial calcification mediated by Wnt/β‐catenin signalling through reduced maximal respiration. Mitochondrial dynamics may therefore represent a novel therapeutic target for clinical intervention.This article is protected by copyright. All rights reserved.

Osteocalcin Regulates Arterial Calcification Via Altered Wnt Signaling and Glucose Metabolism

OGT-Mediated KEAP1 Glycosylation Accelerates NRF2 Degradation Leading to High Phosphate-Induced Vascular Calcification in Chronic Kidney Disease

Oxidative Phosphorylation Promotes Vascular Calcification in Chronic Kidney Disease

Vascular Calcification in Chronic Kidney Disease is Induced by Bone Morphogenetic Protein-2 Via a Mechanism Involving the Wnt/β-Catenin Pathway

Osteocalcin attenuates high fat diet-induced impairment of endothelium-dependent relaxation through Akt/eNOS-dependent pathway

CCAAT/Enhancer-Binding Protein Alpha Is a Novel Regulator of Vascular Smooth Muscle Cell Osteochondrogenic Transition and Vascular Calcification

[Effects of High Glucose on Expression of Core Binding Factor Alpha1 and Osteocalcin in Vascular Smooth Muscle Cells].

C-Type Natriuretic Peptide Inhibiting Vascular Calcification Might Involve Decreasing Bone Morphogenic Protein 2 and Osteopontin Levels

The Protective Effect of GLP-1 Analogue in Arterial Calcification Through Attenuating Osteoblastic Differentiation of Human VSMCs

Adiponectin Attenuates the Osteoblastic Differentiation of Vascular Smooth Muscle Cells Through the Ampk/Mtor Pathway

Osteocalcin Improves Metabolic Profiles, Body Composition and Arterial Stiffening in an Induced Diabetic Rat Model.

Oxidative stress contributes to vascular calcification in patients with chronic kidney disease.

Omentin Inhibits Osteoblastic Differentiation of Calcifying Vascular Smooth Muscle Cells Through the PI3K/Akt Pathway

Role of Macrophage-derived Osteoclasts in Vascular Calcification

Klotho/FGF23 axis mediates high phosphate‐induced vascular calcification in vascular smooth muscle cells via Wnt7b/β‐catenin pathway

Nε-Carboxymethyl-Lysine Mediates Vascular Calcification in Diabetes Caused by Impaired Osteoclastic Resorption Activity Through NFATc1-GNPTAB

Sclerostin is Involved in Osteogenic Transdifferentiation of Vascular Smooth Muscle Cells in Chronic Kidney Disease-Associated Vascular Calcification with Non-Canonical Wnt Signaling.

The Crosstalk Between Endothelial Cells and Vascular Smooth Muscle Cells Aggravates High Phosphorus-Induced Arterial Calcification

Effect of High Glucose Levels on the Calcification of Vascular Smooth Muscle Cells by Inducing Osteoblastic Differentiation and Intracellular Calcium Deposition Via BMP-2/Cbfα-1 Pathway

Mechanisms of the Osteogenic Switch of Smooth Muscle Cells in Vascular Calcification: WNT Signaling, BMPs, Mechanotransduction, and EndMT

Wnt signaling contributes to vascular calcification by induction of matrix metalloproteinases